The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of neoadjuvant abiraterone plus or minus cabazitaxel in high-risk prostate cancer: ACDC-RP.
 
Neil E. Fleshner
Leadership - POINT Biopharma
Stock and Other Ownership Interests - Verity Pharmaceuticals
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Sanofi (Inst); Spectracure (Inst)
 
Aaron Richard Hansen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck; Novartis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BioNTech (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Neoleukin Therapeutics (Inst); Pfizer/EMD Serono (Inst); Roche/Genentech (Inst)
 
Joseph Chin
Consulting or Advisory Role - Abbvie; Astellas Pharma; Johnson & Johnson; Sanofi; TerSera
Research Funding - Johnson & Johnson (Inst); Profound Medical (Inst)
 
Eric Winquist
Consulting or Advisory Role - Amgen; Bayer; Eisai; Ipsen; Merck; Roche
Research Funding - Ayala Pharmaceuticals (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Theodorus Van Der Kwast
Honoraria - Janssen Diagnostics
Consulting or Advisory Role - Janssen
 
Katherine Lajkosz
No Relationships to Disclose
 
Miran Kenk
No Relationships to Disclose
 
Doron Berlin
No Relationships to Disclose
 
Rosette Veloso
No Relationships to Disclose
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Robert James Hamilton
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Girish S. Kulkarni
Honoraria - Abbvie; BioSyent; Tersera
Consulting or Advisory Role - Ferring; Janssen Oncology; Merck; Theralase
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Johnson & Johnson/Janssen; Medtronic
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Merck; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
 
Alexandre R. Zlotta
Stock and Other Ownership Interests - iTP Biomedica
Honoraria - mIR Scientific; Theralase; Verity Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; BioSyent; Ferring; Merck; mIR Scientific; Sanofi; Theralase; Verity Pharmaceuticals
Research Funding - AstraZeneca (Inst); Ferring (Inst); Merck (Inst); Sanofi (Inst); Verity Pharmaceuticals (Inst)
 
Anthony M. Joshua
Stock and Other Ownership Interests - Pricilium Therapeutics
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Merck Serono (Inst); Neoleukin Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)